This revolutionary approach has given hope to patients who previously had limited or no options, particularly those battling ...

So far, nothing we’ve been able to create can replace blood. “Whole blood” consists of three different types of cells (red ...

A new research paper was published in Oncotarget, Volume 16, on March 21, 2025, titled “NSD2-epigenomic reprogramming and ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...

Wojciech Jurczak, MD, PhD, ​​discusses the future of B-cell lymphoma therapy, with a focus on Bruton's tyrosine kinase ...

What Is B-Cell Lymphoma? B-cell lymphoma is a cancer that forms in your white blood cells called lymphocytes. These cells are made by your lymphatic system, which plays an important role in immunity.

Last November, results from the MITIGATE trial made headlines at ACR Convergence 2024 with positive phase 3 trial data for inebilizumab, an IgG1 monoclonal antibody targeting CD19, in patients with ...

New monoclonal antibodies or fusion proteins that specifically target B-cell survival or proliferation are, however, now becoming available. BCMA Stimulates plasma cell survival and IgM production ...

Plasma cells originate in lymphoid (immune) tissues and then migrate to protected sites throughout the body, where they produce large amounts of antibodies in response to infection-related substances.

Researchers from Osaka University find that in immune tissues, plasma cells that express certain proteins are more likely to migrate to the bone marrow, where they help create long-lasting antibod ...